• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Haemonetics Corporation Common Stock (NY:HAE)

104.37 UNCHANGED
Delayed Quote Updated: 7:00 PM EDT, Oct 1, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 104.37
Bid (Size) 103.50 (300)
Ask (Size) 105.50 (200)
Prev. Close 104.37
Today's Range 104.37 - 104.37
52wk Range 47.72 - 110.45
Shares Outstanding 51,029,618
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
3 Small-Cap Stocks with Questionable Fundamentals
October 01, 2026
Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and... 
Via StockStory
Haemonetics (NYSE:HAE): A Quality Investing Candidate Built on Durable Fundamentals ↗
September 26, 2026
Via Chartmill

Performance

YTD
+30.5%
+30.5%
1 Month
+2.4%
+2.4%
3 Month
+39.0%
+39.0%
6 Month
+83.7%
+83.7%
1 Year
+113.8%
+113.8%

More News

Read More
News headline image
1 Momentum Stock with Competitive Advantages and 2 We Avoid
September 17, 2026
Via StockStory
Topics Artificial Intelligence
News headline image
Orchestra BioMed Receives $6.1 Million Milestone Payment from Acquisition of Vivasure by Haemonetics
September 15, 2026
From Orchestra BioMed Holdings, Inc.
Via GlobeNewswire
Haemonetics (NYSE:HAE) Shines in Quality Investing Screen ↗
August 15, 2026
Via Chartmill
News headline image
2 Momentum Stocks with Exciting Potential and 1 We Avoid
August 24, 2026
Via StockStory
News headline image
Winners And Losers Of Q2: Haemonetics (NYSE:HAE) Vs The Rest Of The Medical Devices & Supplies - Specialty Stocks
August 20, 2026
Via StockStory
News headline image
1 Russell 2000 Stock with Competitive Advantages and 2 We Turn Down
August 20, 2026
Via StockStory
News headline image
Haemonetics Shares Hit New 52-Week High: What's Happening? ↗
August 18, 2026
Via Benzinga
Tuesday's session: gap up and gap down stocks ↗
August 18, 2026
Via Chartmill
News headline image
1 Unpopular Stock That Deserves a Second Chance and 2 We Avoid
August 17, 2026
Via StockStory
News headline image
Haemonetics (HAE) Q1 2027 Earnings Call Transcript ↗
August 13, 2026
Via The Motley Fool
Topics Earnings
News headline image
5 Insightful Analyst Questions From Haemonetics’s Q2 Earnings Call
August 13, 2026
Via StockStory
Topics Earnings
News headline image
Haemonetics Q1 Earnings Call Highlights ↗
August 08, 2026
Via MarketBeat
Topics Earnings
News headline image
HAE Q2 Deep Dive: Plasma and Interventional Growth Drive Outperformance, Margin Outlook Steady
August 07, 2026
Via StockStory
Topics World Trade
News headline image
Haemonetics (NYSE:HAE) Beats Q2 CY2026 Sales Expectations
August 06, 2026
Via StockStory
News headline image
What To Expect From Haemonetics’s (HAE) Q2 Earnings
August 04, 2026
Via StockStory
News headline image
1 Cash-Producing Stock with Promising Prospects and 2 That Underwhelm
July 28, 2026
Via StockStory
News headline image
3 Healthcare Stocks with Questionable Fundamentals
July 23, 2026
Via StockStory
News headline image
1 Small-Cap Stock Worth Your Attention and 2 That Underwhelm
July 15, 2026
Via StockStory
News headline image
3 Reasons HAE is Risky and 1 Stock to Buy Instead
June 30, 2026
Via StockStory
Topics Stocks Supply Chain
News headline image
3 Profitable Stocks We Find Risky
June 26, 2026
Via StockStory
News headline image
Haemonetics (HAE) Stock Is Up, What You Need To Know
May 22, 2026
Via StockStory
News headline image
Medical Devices & Supplies - Specialty Stocks Q1 Highlights: Haemonetics (NYSE:HAE)
May 20, 2026
Via StockStory
News headline image
3 Russell 2000 Stocks That Concern Us
May 18, 2026
Via StockStory

Frequently Asked Questions

Is Haemonetics Corporation Common Stock publicly traded?
Yes, Haemonetics Corporation Common Stock is publicly traded.
What exchange does Haemonetics Corporation Common Stock trade on?
Haemonetics Corporation Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Haemonetics Corporation Common Stock?
The ticker symbol for Haemonetics Corporation Common Stock is HAE on the New York Stock Exchange
What is the current price of Haemonetics Corporation Common Stock?
The current price of Haemonetics Corporation Common Stock is 104.37
When was Haemonetics Corporation Common Stock last traded?
The last trade of Haemonetics Corporation Common Stock was at 10/01/26 07:00 PM ET
What is the market capitalization of Haemonetics Corporation Common Stock?
The market capitalization of Haemonetics Corporation Common Stock is 5.33B
How many shares of Haemonetics Corporation Common Stock are outstanding?
Haemonetics Corporation Common Stock has 5B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap